Literature DB >> 4603012

Renal deposition of soluble immune complexes in mice bearing B-16 melanoma. Characterization of complexes and relationship to tumor progress.

P K Poskitt, T R Poskitt, J H Wallace.   

Abstract

Histologic and immunofluorescence studies of the kidneys of mice bearing a progressive melanoma show a proliferative glomerulonephritis associated with immune complex deposition in the mesangium and along the glomerular basement membrane This immune complex disease is distinct from the age-associated disease of the C57BL/6J host strain and the complexes can be shown to consist of soluble tumor antigen and antitumor antibody. Furthermore, the intensity of IgG complex deposition correlates directly with tumor progress (size and metastases) and inversely with mononuclear leukocyte infiltration of the tumor. In vitro assays for lymphocyte cytotoxicity and humoral antibody were found to be less reliable indicators of tumor progress. The possible role of circulating soluble tumor antigen in modifying the immune response to tumors is discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4603012      PMCID: PMC2139594          DOI: 10.1084/jem.140.2.410

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Nephrotic syndrome in malignant disease of non-renal origin.

Authors:  L W Loughridge; M G Lewis
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

2.  Immunologic and electron microscopic studies in Goodpasture's syndrome.

Authors:  T R Poskitt
Journal:  Am J Med       Date:  1970-08       Impact factor: 4.965

3.  Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells.

Authors:  L Fass; R B Herberman; J L Ziegler; J W Kiryabwire
Journal:  Lancet       Date:  1970-01-17       Impact factor: 79.321

4.  Histology and prognosis in malignant melanoma.

Authors:  A J Cochran
Journal:  J Pathol       Date:  1969-03       Impact factor: 7.996

5.  Nephrotic syndrome: a prodrome to lymphoma.

Authors:  L Ghosh; R C Muehrcke
Journal:  Ann Intern Med       Date:  1970-03       Impact factor: 25.391

6.  Acute nephrotic syndrome as a manifestation of active Hodgkin's Disease. Report of four cases and review of the literature.

Authors:  J Plager; L Stutzman
Journal:  Am J Med       Date:  1971-01       Impact factor: 4.965

7.  Nephrotic syndrome cured by removal of gastric carcinoma.

Authors:  E G Cantrell
Journal:  Br Med J       Date:  1969-06-21

8.  The association of cancer and the nephrotic syndrome.

Authors:  J C Lee; H Yamauchi; J Hopper
Journal:  Ann Intern Med       Date:  1966-01       Impact factor: 25.391

9.  Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.

Authors:  I Hellström; H O Sjögren; G Warner; K E Hellström
Journal:  Int J Cancer       Date:  1971-03-15       Impact factor: 7.396

10.  Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.

Authors:  M G Lewis; R L Ikonopisov; R C Nairn; T M Phillips; G H Fairley; D C Bodenham; P Alexander
Journal:  Br Med J       Date:  1969-09-06
View more
  3 in total

1.  Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma.

Authors:  H M Jansen; T H The; G C de Gast; H A Huiges; M T Esselink; A M van der Wal; N G Orie
Journal:  Thorax       Date:  1977-12       Impact factor: 9.139

2.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

3.  Immune complexes in peripheral blood polymorphonuclear leucocytes of malignant melanoma patients.

Authors:  T H The; M van der Giessen; H A Huiges; H Schraffordt Koops; I van Wingerden
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.